<DOC>
	<DOCNO>NCT02897895</DOCNO>
	<brief_summary>The study interventional , multicentre , prospective , randomize , control , single-blind , comparative trial two process adjust inhibitor calcineurin ( CNI ) dosage lung transplant recipient . Recipients stratify transplant center accord underlie lung disease ( affected cystic fibrosis ) randomize either evaluation calcineurin activity ( CN-a ) combination CNI blood level versus CNI blood level alone 1:1 ratio . The objective compare proportion acute rejection require specific curative treatment 6 month transplantation patient two group .</brief_summary>
	<brief_title>Study Evaluate Value Follow-up CALCIneurin Activity MOdulate Calcineurin Inhibitors-induced Immunosuppression Lung Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Patient place national wait list lung transplantation First de novo lung transplantation ( single double LTx ) Prevention allograft rejection usual immunosuppressive regimen include CNI ( cyclosporine tacrolimus ) Previous lung transplantation solid organ transplantation Combined lung transplantation either liver renal transplantation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Lung transplantation end-stage lung disease</keyword>
</DOC>